Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Lantheus Holdings, Inc. (LNTH)

62.82   1.53 (2.5%) 06-26 22:58
Open: 62.33 Pre. Close: 61.29
High: 64.32 Low: 61.01
Volume: 2,899,719 Market Cap: 4,312(M)
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 64.4 - 64.66 64.66 - 64.91
Low: 60.38 - 60.66 60.66 - 60.93
Close: 62.37 - 62.81 62.81 - 63.23

Technical analysis

as of: 2022-06-24 4:41:24 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 79.66     One year: 86.17
Support: Support1: 59.18    Support2: 49.23
Resistance: Resistance1: 68.2    Resistance2: 73.77
Pivot: 64.11
Moving Average: MA(5): 61.36     MA(20): 65.6
MA(100): 55.26     MA(250): 37.92
MACD: MACD(12,26): -1     Signal(9): -0.4
Stochastic oscillator: %K(14,3): 15.3     %D(3): 13.4
RSI: RSI(14): 47.9
52-week: High: 73.77  Low: 22.2
Average Vol(K): 3-Month: 1,266 (K)  10-Days: 1,372 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ LNTH ] has closed above bottom band by 42.3%. Bollinger Bands are 22.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 25 Jun 2022
Lantheus Hosts Inaugural Inves -

Sat, 25 Jun 2022
UnitedHealth, Shockwave Lead 5 Healthy Stocks Breaking Out Or Setting Up - Investor's Business Daily

Thu, 23 Jun 2022
UnitedHealth (UNH) Unit Unveils Solution to Provide Better Care - Nasdaq

Sun, 19 Jun 2022
I've Got an Options Bandage for a Sick Economy - RealMoney

Sat, 18 Jun 2022
Lantheus Holdings, Inc. (NASDAQ:LNTH) CAO Andrea Sabens Sells 386 Shares - Defense World

Fri, 10 Jun 2022
Is Lantheus Holdings Inc (LNTH) a Smart Choice in Diagnostics & Research Friday? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 68 (M)
Shares Float 67 (M)
% Held by Insiders 2.4 (%)
% Held by Institutions 100.6 (%)
Shares Short 2,370 (K)
Shares Short P.Month 2,280 (K)

Stock Financials

EPS -0.51
EPS Est Next Qtl 0.23
EPS Est This Year 1.12
EPS Est Next Year 1.14
Book Value (p.s.) 7.38
Profit Margin (%) -6.9
Operating Margin (%) 11.5
Return on Assets (ttm) 4.3
Return on Equity (ttm) -7.2
Qtrly Rev. Growth 125.8
Gross Profit (p.s.) 2.77
Sales Per Share 8
EBITDA (p.s.) 1.6
Qtrly Earnings Growth 369.2
Operating Cash Flow 54 (M)
Levered Free Cash Flow 77 (M)

Stock Valuations

PE Ratio -123.18
PEG Ratio 0.4
Price to Book value 8.51
Price to Sales 7.85
Price to Cash Flow 78.22

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.